Butorphanol Tartrate - Indications, Side Effects, and Pharmacological Aspects

Overview

Nasal spray with Butorphanol tartrate relieves moderate to severe pain. It is a member of the class of drugs known as opioid agonist-antagonists, which function by modifying how the body perceives pain. The nasal spray containing Butorphanol tartrate was approved by the United States Food and Drug Administration (USFDA) on 12th March 2002.

Drug Group:

Butorphanol is a member of the class of medications known as opioid agonist-antagonists.

Available Doses and Dosage Forms:

• For Mild Pain: Starting with one milligram (one spray in one nostril) is advised. If adequate pain relief is not obtained in sixty to ninety minutes, one more dose of one milligram may be given. If required, repeat this cycle every three to four hours.

• For Severe Pain: Patients who can stay in bed may be given an initial dose of two milligrams (one spray in each nostril) if they experience sleepiness or dizziness. A further dose should be avoided for three to four hours because of the increased risk of side effects.

• Elderly people or those with kidney or liver disease should take only one milligram first. If necessary, a second dose of one milligram should be given 90 to 120 minutes later. The timing of subsequent doses should depend on each patient's response, usually six hours apart.

For Patients

What Is Pain?

The nervous system uses pain as a signal to potentially identify a problem. It feels like burning, tingling, pricking, or hurting, with some variations in sharpness and dullness. The stomach, back, chest, and pelvic regions can all be affected by pain, which can be localized or widespread. It is essential for problem diagnosis, damage prevention, and underlying medical condition identification. The two main kinds of pain are chronic and acute. Acute pain occurs rapidly due to an injury, disease, or inflammation and normally goes away with treatment. In contrast, chronic pain lasts for a long time and can be very difficult to manage. Pain can be controlled with various therapies depending on its type and origin, even if it is not always curable.

How Does Butorphanol Tartrate Work?

Butorphanol selectively inhibits pain impulses in specific brain and spinal cord regions. It is believed to interact with opiate receptor sites in the central nervous system, though the precise mechanism is still unclear.

What Are the Things to Inform the Doctor Before Taking Butorphanol Tartrate?

When using Butorphanol nasal spray, people should disclose to their doctor any allergies, prescription drugs, and medical problems, including any past surgical procedures and breastfeeding status. Given the potential for interactions, disclosing all medications taken, including over-the-counter pharmaceuticals and herbal supplements, is imperative. Patients should avoid driving or using machinery during the first hour following administration and be mindful of possible adverse effects such as sleepiness, dizziness, and fainting. Constipation can also happen. Therefore, patients should talk to their doctor about therapy options. To ensure the safe and efficient use of Butorphanol nasal spray, individuals must adhere closely to the advice provided by their healthcare professionals.

How Is Butorphanol Tartrate Administered?

Butorphanol nasal spray is a medicated liquid that relieves pain and is administered through the nose. It should be taken as needed and not more than once every three to four hours. If a patient has any questions, they should ask their doctor or pharmacist and carefully follow the directions on their prescription label. The physician may prescribe a second dose if the discomfort does not go away 60 to 90 minutes after the initial dosage. However, patients must obtain their doctor's consent before taking this second dose. Patients should call their doctor if the discomfort does not go away even after taking the medication as prescribed. Furthermore, individuals should notify their physician if the medicine loses effectiveness over time.

It is crucial to talk to the doctor before abruptly stopping the Butorphanol nasal spray because doing so could cause withdrawal symptoms. Some of these symptoms are anxiety, diarrhea, and trouble sleeping. If these symptoms are to be avoided, the doctor may progressively reduce the dosage. Patients should read the manufacturer's instructions and ask their doctor or pharmacist any questions before taking the nasal spray for the first time.

Before using the nasal spray containing Butorphanol, people should wash their hands thoroughly for proper hygiene. To remove any obstacles, they must then carefully blow their nostrils. According to the instructions, the pump needs to be primed (the solution is filled into the pump casing, the air is forced out of the casing, and an impeller-to-casing seal is made) if it is brand-new or has not been used in 48 hours. Gently sniff the spray through one nostril into which the sprayer is inserted, then do the same with the other. The bottle must be stored securely, and its protective cover must be replaced after each use.

Dietary Instructions:

A special diet is to be followed only if instructed by the doctor.

Side Effects:

Side effects from Butorphanol nasal spray can include flushing (skin reddening), constipation, stomach ache, tiredness, impaired vision, and dry mouth. Severe side effects include decreased breathing, dizziness, confusion, rapid heartbeat, vomiting, and trouble breathing could occur. Other severe symptoms could be decreased desire for sexual activity, irregular menstruation, weakness, nausea, lack of appetite, dizziness, or difficulty maintaining an erection. It is imperative to see a doctor immediately if a patient experiences any of these symptoms. People should also report odd side effects to their healthcare provider while taking Butorphanol nasal spray.

Missed Dose:

Usually, Butorphanol nasal spray is applied as needed. When taking Butorphanol nasal spray regularly, if a person needs to remember to take a dose, they should take it as soon as they remember. On the other hand, if the next dose is almost due, they should disregard the missed one and resume their regular regimen. Avoiding taking two doses to catch up is crucial.

Overdose:

If someone takes too much Butorphanol nasal spray, they should contact the emergency service immediately. A seizure (an uncontrollable spike in electrical activity between brain cells), trouble breathing, or unconsciousness are the signs for contacting emergency care.

It is essential to discuss the availability of the rescue medicine Naloxone with a physician before using the Butorphanol nasal spray. The dangerous effects of an overdose can be reversed using Naloxone. Naloxone may also be prescribed by a physician if the home has young children or if any family members take narcotics. Individuals who overdose and their families should know how to identify an overdose, give Naloxone, and wait for medical help. People can get advice from a doctor or pharmacist on using Naloxone, and they should make sure they comprehend the directions. If symptoms return before medical help arrives, be ready to give extra doses of Naloxone every two to three minutes. Breathing slowly, having trouble breathing, feeling sleepy, and losing consciousness are all indicators of an overdose.

Storage:

Keep Butorphanol nasal spray tightly closed, out of children's reach, and in its child-resistant container. It ought to be stored at room temperature, out of the bathroom, and away from extreme heat and moisture sources. Remove the cap, rinse the bottle, and put the components in the garbage container to eliminate expired or unused medication. To prevent accidental poisoning, it is crucial to keep all medications out of sight and reach of children. Medication should always be kept out of sight and accessible and promptly stored in a secure area with locked safety caps.

For Doctors

• Indication: When a painkiller with an opioid is appropriate, Butorphanol tartrate NS and Butorphanol tartrate injection are used to manage pain. Additionally, Butorphanol injection can be used to reduce childbirth pain, as part of balanced anesthesia, or before surgery or anesthesia.

• Contraindication: Patients with a history of allergy to Butorphanol tartrate or the preservative benzethonium chloride in Butorphanol NS and Butorphanol injection should avoid taking them.

What Are the Pharmacological Aspects of Butorphanol Tartrate?

• Mechanism of Action

  • Butorphanol blocks some brain and spinal cord regions that receive pain signals. Though the exact mode of action is unknown, it probably interacts with opioid receptor sites in the central nervous system, potentially even in the limbic system.

  • Butorphanol is a partial agonist at the mu-opioid receptor and a full agonist at the kappa-opioid receptor. Its primary goal is to relieve pain.

• Pharmacodynamics

  • Butorphanol has different analgesic effects depending on the mode of administration. The fastest onset, usually within minutes, is achieved with intravenous delivery. It is closely followed by intramuscular injection, which starts in about 15 minutes. Doses administered by nasal spray also have a quick start, usually within 15 minutes.

  • When administered intravenously or intramuscularly, the highest analgesic effect is shown 30 to 60 minutes later. However, when administered nasally, the peak analgesic activity occurs one to two hours later.

  • Several variables, including the administration method and the pain model, affect how long analgesia lasts. Analgesia is usually maintained for three to four hours with intramuscular and intravenous doses, as indicated by when 50 percent of patients need to be corrected. In postoperative trials, the duration of analgesia with intramuscular or intravenous Butorphanol, when given at equipotent doses, is similar to that of Morphine, Meperidine, and Pentazocine.

  • With a four to five-hour half-life, Butorphanol tartrate nasal spray has a longer duration of action than other medications in its class and its injectable form.

• Pharmacokinetics

  • When taken as a muscle injection or nasal spray, Butorphanol tartrate reaches peak blood levels at various times. The muscle injection peaks in 20 to 40 minutes, while the nasal spray peaks in 30 to 60 minutes. Although nasal spray may reduce absorption, it has little effect on the amount absorbed, which normally varies from 60 to 70 percent.

  • Regardless of the mode of delivery, Butorphanol tartrate behaves consistently once absorbed. It mostly binds to blood proteins and is expelled by urine at a rate of 52 to 154 liters per hour.

  • Higher peak levels are achieved with regular use, up to 1.8 times after the first dose and maybe up to three times in certain people. Regular users may need a few days to achieve a stable drug level in their bodies.

  • The medication can enter the brain, placenta, and breast milk. When taken orally, the liver breaks it down significantly, with hydroxy Butorphanol being the main metabolite.

  • Hydroxy Butorphanol can accumulate over five times the recommended dosage and stays in the body for around 18 hours. Urine is the primary means of excretion, though some are also passed in the stool.

  • Renal or hepatic problems might affect an individual's elimination rates and buildup, with slower elimination and higher accumulation noted in these cases. Furthermore, older people and women may metabolize or absorb the medication differently than younger, healthier people.

Toxicity (Carcinogenesis, Mutagenesis, and Infertility):

A two-year study was conducted in mice and rats to assess Butorphanol tartrate for carcinogenicity. Even at large levels, neither species developed cancer from it. Additionally, tests revealed no harm to human or bacterial cell genes. Rats found it more difficult to conceive when given a very high dose but not when given a lesser level.

Warnings and Precautions:

• General: Within the first hour of using Butorphanol NS, it has been reported that patients who have previously suffered comparable reactions to opioid medicines may develop low blood pressure and faint.

• Narcotic Dependence: Since Butorphanol can mitigate the effects of opioids, it is not recommended for use in individuals who are dependent on drugs. Individuals undergoing Butorphanol therapy must first go through an opioid withdrawal period. However, Butorphanol can cause withdrawal symptoms from opioid medicines, including agitation, anxiety, hallucinations, mood swings, sadness, weakness, and diarrhea in individuals who take them regularly.

• Drug Abuse and Dependence: It is possible to abuse Butorphanol tartrate, particularly in nasal spray form. Physical dependence or tolerance, in which the body requires more of the drug to have the same effect, can result from long-term use. In individuals who are reliant on the medicine, abruptly quitting it can result in withdrawal symptoms.

• Head Injury: Similar to other opioids, Butorphanol use in individuals with head trauma may result in side effects such as carbon dioxide retention, elevated cerebrospinal fluid pressure, constricted pupils, and altered mental status.

• Disorder of Respiratory Function: Patients taking other medications that influence the central nervous system (CNS) and those with respiratory issues or CNS illnesses may experience slower breathing when using Butorphanol.

• Kidney and Liver Disease: The recommended starting dose of Butorphanol injection for individuals with liver or kidney issues is usually half the recommended adult dose. Depending on the patient's response, more doses should be placed at least six hours apart.

• Cardiovascular Effects - Butorphanol should be taken carefully in individuals with recent heart attacks, problems with the heart ventricle, or reduced heart blood flow since it can put stress on the heart, particularly the lungs. If severe hypertension develops while taking Butorphanol, the medicine should be withdrawn, and other forms of high blood pressure management should be pursued. Naloxone is also beneficial for individuals who are not opioid-dependent.

• Use in Ambulatory Patients

  • People who take Butorphanol may experience drowsiness or vertigo, especially in the first hour after taking it. Until they feel normal again, they should refrain from operating machinery or driving.

  • When using Butorphanol, alcohol consumption should be avoided. If combined with other brain-damaging medicines, it may exacerbate drowsiness, vertigo, or mental impairment.

  • People should take caution when handling Butorphanol because it can be abused.

  • Butorphanol NS should be used with caution.

Drug Interaction:

• Butorphanol can intensify the effects of other medications that influence the central nervous system, such as barbiturates, tranquilizers, alcohol, or antihistamines. Therefore, when using Butorphanol with these other medications, it is crucial to utilize the lowest effective dose and cut back on how often you take it.

• Time of day is important when taking Butorphanol and the migraine medication Sumatriptan. Butorphanol may become less effective after Sumatriptan; however, this effect is negligible if taken 30 minutes later. Since both Butorphanol tartrate NS and Sumatriptan nasal spray can momentarily raise blood pressure, it is unclear if using them together during a migraine attack is safe.

• Cimetidine, a medication used to treat stomach ulcers, is not affected by Butorphanol when used together.

• Although it is unclear if medications that impact liver metabolism, such as Theophylline or Erythromycin, would change Butorphanol's effects, caution is advised, and a lower starting dose might be required.

• Combining Butorphanol tartrate NS with a nasal decongestant (such as Oxymetazoline) does not alter the amount absorbed but may cause it to act more slowly.

Clinical Studies:

A study examined the effectiveness of intranasal Butorphanol in reducing moderate to severe pain following the extraction of impacted third molars compared to a placebo. They compared the outcomes of 151 patients who received varying dosages of Butorphanol. Within the first hour, the larger doses (one milligram and two milligrams) provided better pain alleviation than the placebo. Butorphanol also had a rapid half-life, often working in fifteen minutes. Increased dosages, however, were associated with an increased risk of adverse symptoms such as fatigue and vertigo. The study concluded that although intranasal Butorphanol may be useful in treating dental pain, caution should be exercised because of possible adverse effects.

Specific Considerations:

• Pregnancy: Studies on pregnant women using Butorphanol tartrate are insufficient to determine its effects before 37 weeks of pregnancy. When using Butorphanol tartrate during pregnancy, the advantages should be greater than the possible hazards to the unborn child.

• Labor and Delivery: Rarely, newborns who received an injection of Butorphanol tartrate during delivery have been reported to have trouble breathing. This was more common when the drug was administered near the time of delivery, in conjunction with other analgesics or painkillers, or in cases of preterm births. Butorphanol tartrate injection should be cautiously used if the baby's heart rate changes unexpectedly. Because the effects of Butorphanol tartrate NS in labor and delivery have yet to be explored, using it during these times is not advised.

• Nursing Mother: Breastfeeding moms who had an injection of Butorphanol tartrate have shown evidence of Butorphanol in their milk. A baby would receive a very little and clinically insignificant quantity. It is anticipated that Butorphanol, when taken through the nose, will likewise be present in breast milk in comparable proportions, even though there is no direct experience with the nasal spray form of Butorphanol tartrate among nursing mothers.

• Pediatric Patients: Since there is insufficient evidence of Butorphanol's safety and effectiveness in this age group, administering medication to anyone younger than 18 is not recommended.

• Geriatric Patients: Butorphanol tartrate injection and nasal spray were used to treat a limited number of elderly patients in clinical trials. This group may be more susceptible to side effects like headache, nausea, vomiting, vertigo, sleepiness, and nasal congestion.